Full-length sequence (1–264 amino acids):
MDMREVYVVAGSFVGFQLFFSCVSPVLSSNFTQGYGKLPPNKLNDWNSRLVSTVHALIVG LFCLYILWYDDAVNEDPVWGDPNLVKLNVAITCGYLFYDLLLLACNWSTMGDVFFVCHHL AALYAYGYVLTRGVLPYFANFRLISELSTPFVNQRWFFEALAYPRTHQLVVANGIAMAVV FFLVRIAVMPPYWAKVFGIIYSPTFEKLGLAIQVAWIISCVCLDILNIIWMYKIARGCYK VITGKLKGRKADSKKTTCVNNHTD .
Molecular Weight: ~30 kDa (theoretical).
Post-Translational Modifications: Multi-pass transmembrane domains; tags (e.g., His) are added during recombinant production .
| Attribute | Details |
|---|---|
| Gene Name | tmem56b (synonyms: tlcd4b, zgc:92864) |
| UniProt ID | Q5XIY2 |
| KEGG Entry | dre:449652 |
| Subcellular Localization | Membrane; multi-pass transmembrane protein |
| Protein Family | TMEM56 family |
tmem56b is implicated in critical cellular processes:
Vesicle Trafficking: Facilitates formation, fusion, and recycling of vesicles, essential for nutrient uptake and neurotransmission .
Disease Associations:
Cancer Mechanisms:
Erythroid Differentiation:
Zebrafish Behavioral Models:
Transmembrane protein 56-B (tmem56b) is a 264-amino acid protein expressed in Danio rerio (zebrafish). It belongs to the broader TMEM56 family found across various species. The protein has a complete amino acid sequence of MDMREVYVVAGSFVGFQLFFSCVSPVLSSNFTQGYGKLPPNKLNDWNSRLVSTVHALIVGLFCLYILWYDDAVNEDPVWGDPNLVKLNVAITCGYLFYDLLLLACNWSTMGDVFFVCHHLALYAYGYVLTRGVLPYFANFRLISELSTPFVNQRWFFEALAYPRTHQLVVANGIAMAVVFFLVRIAVMPPYWAKVFGIIYSPTFEKLGLAIQVAWIISCVCLDILNIIWMYKIARGCYKVITGKLKGRKADSKKTTCVNNHTD .
The protein is also known by synonyms including tmem56, zgc:92864, and TLC domain-containing protein 4-B . While research on zebrafish tmem56b is still emerging, studies on human TMEM56 indicate important roles in cellular processes including erythropoiesis and haem metabolism .
For research purposes, E. coli expression systems have been successfully employed to produce recombinant tmem56b protein . The choice of expression system depends on research objectives:
| Expression System | Advantages | Limitations | Optimal Applications |
|---|---|---|---|
| E. coli | Cost-effective, high yield, rapid production | Limited post-translational modifications | Structural studies, antibody production |
| Mammalian cells | Native-like post-translational modifications | Higher cost, lower yield | Functional studies, complex interaction analyses |
| Insect cells | Moderate post-translational modifications, higher yield than mammalian | More complex than bacterial systems | Balance between yield and protein authenticity |
When expressing tmem56b in E. coli, researchers typically fuse the protein with tags (such as His-tag) to facilitate purification while maintaining protein functionality .
Proper storage and handling of recombinant tmem56b is critical for maintaining protein integrity and experimental reproducibility. Based on established protocols, the following guidelines are recommended:
Store the lyophilized powder of recombinant tmem56b at -20°C/-80°C upon receipt .
After reconstitution, add glycerol to a final concentration of 50% and aliquot for long-term storage at -20°C/-80°C to prevent repeated freeze-thaw cycles .
For working solutions, store aliquots at 4°C for up to one week .
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL .
Brief centrifugation of the vial is recommended prior to opening to bring contents to the bottom .
Repeated freezing and thawing significantly reduces protein activity and should be avoided to maintain experimental integrity .
When investigating tmem56b function in zebrafish, researchers should employ rigorous experimental designs that account for potential confounding variables. Based on experimental design principles, the following approaches are recommended:
A randomized block design is particularly suited for tmem56b studies in zebrafish, as it controls for variance related to clutch-specific effects or developmental timing . This design allows researchers to isolate the effects of tmem56b manipulation while controlling for batch effects between experimental groups.
For investigating tmem56b function:
Control selection: Include appropriate controls such as wild-type samples, scrambled morpholinos (for knockdown studies), or empty vector controls (for overexpression studies).
Sample size calculation: Determine adequate sample sizes using power analysis based on expected effect sizes from preliminary data.
Factorial design considerations: When exploring interactions between tmem56b and other factors (e.g., environmental conditions, genetic backgrounds), implement factorial designs to systematically test all possible combinations .
Quantification metrics: Establish clear, objective metrics for phenotypic assessment, preferably using automated image analysis to minimize observer bias.
The coefficient of determination (r²) should be calculated to assess goodness of fit for any quantitative analyses, with values above 0.6 typically indicating robust relationships in biological systems .
Several complementary approaches can be employed to investigate tmem56b interactions with other proteins:
| Technique | Principle | Advantages | Limitations |
|---|---|---|---|
| Co-immunoprecipitation (Co-IP) | Precipitation of protein complexes using specific antibodies | Detects native interactions | Requires high-quality antibodies against tmem56b |
| Proximity Ligation Assay (PLA) | Fluorescent detection of proteins in close proximity | Visualizes interactions in situ | May detect proximity rather than direct interaction |
| Bioluminescence Resonance Energy Transfer (BRET) | Energy transfer between luminescent donor and fluorescent acceptor | Real-time detection in living cells | Requires protein tagging which may affect function |
| Yeast Two-Hybrid (Y2H) | Transcriptional activation upon protein interaction | High-throughput screening capability | High false positive/negative rates |
The NanoBRET platform has been successfully used for analyzing protein-protein interactions in related transmembrane proteins and could be adapted for tmem56b studies . This approach offers quantitative measurement of protein interactions with high sensitivity.
For co-immunoprecipitation studies, researchers should consider:
Using lysates prepared with 4 M urea and 10% (w/v) SDS without reducing agents to preserve membrane protein interactions .
Sonicating and centrifuging lysates at >16,000 g for 30 minutes to ensure proper protein extraction .
Employing tagged versions (e.g., His-tagged tmem56b) to facilitate pull-down experiments when specific antibodies are unavailable .
Recent research on human TMEM56 provides insights into potential functions of zebrafish tmem56b. Studies using CD34+ hematopoietic stem cells demonstrate that TMEM56 deficiency disrupts haem biosynthesis and impairs erythroid differentiation .
Key findings that may inform zebrafish tmem56b research include:
TMEM56 is abundantly expressed in erythroid cells, suggesting cell type-specific functions .
Loss of TMEM56 leads to defects in haem metabolism, a fundamental process in many cell types .
Deletion of Tmem56 in murine models using erythropoietin receptor (EpoR)-Cre revealed defects in erythroid progenitors within the bone marrow under both normal conditions and during hemolytic anemia .
These findings suggest that zebrafish tmem56b may play regulatory roles in hematopoiesis and specific metabolic pathways. Researchers studying zebrafish tmem56b should consider designing experiments to investigate:
Expression patterns during hematopoietic development
Effects of tmem56b knockdown/knockout on erythroid differentiation
Potential roles in metabolic pathways, particularly those related to haem biosynthesis
Ensuring high-quality recombinant tmem56b is essential for reliable experimental outcomes. Key quality control parameters include:
Purity assessment: SDS-PAGE analysis should demonstrate >90% purity for research applications .
Functional validation: Activity assays appropriate to tmem56b's predicted functions should be conducted to ensure the recombinant protein retains native activity.
Structural integrity: Circular dichroism (CD) spectroscopy can be used to verify proper protein folding, particularly important for transmembrane proteins.
Aggregation analysis: Size-exclusion chromatography or dynamic light scattering should be employed to assess protein monodispersity.
Endotoxin testing: For cell-based applications, endotoxin levels should be quantified and maintained below 1 EU/μg protein.
When reconstituting lyophilized tmem56b, researchers should follow established protocols using deionized sterile water to achieve concentrations of 0.1-1.0 mg/mL . The addition of 5-50% glycerol (with 50% being the default recommendation) helps maintain protein stability during storage .
Transmembrane proteins like tmem56b present unique challenges during recombinant expression and purification. Researchers may encounter these common issues and should consider the following solutions:
| Challenge | Potential Causes | Recommended Solutions |
|---|---|---|
| Low expression yield | Protein toxicity to host cells | Use tightly regulated inducible expression systems |
| Codon bias | Optimize codons for expression host | |
| Formation of inclusion bodies | Lower induction temperature (16-20°C) | |
| Protein aggregation | Improper detergent selection | Screen multiple detergents for optimal solubilization |
| Inadequate stabilization | Add specific lipids or stabilizing agents | |
| Poor purity | Non-specific binding to purification resin | Optimize imidazole concentration in wash buffers |
| Protein degradation | Add protease inhibitors during purification |
For His-tagged tmem56b expressed in E. coli, researchers should consider:
Inducing expression at lower temperatures (16-20°C) to promote proper folding
Using specialized E. coli strains designed for membrane protein expression
Carefully optimizing lysis and purification buffers to maintain protein stability
Adding glycerol (final concentration 50%) to purified protein preparations to enhance stability
When designing gene manipulation experiments to study tmem56b function:
CRISPR/Cas9-based knockouts:
Design guide RNAs targeting conserved functional domains
Include verification of knockout efficiency through sequencing
Establish F2 homozygous mutant lines for reproducible experiments
Morpholino-based knockdown:
Use both translation-blocking and splice-blocking morpholinos
Validate knockdown efficiency by Western blotting
Include rescue experiments with co-injection of morpholino-resistant mRNA
Controls and validation:
Include appropriate controls (scrambled morpholinos, Cas9 only)
Validate phenotypes with multiple targeting approaches
Perform rescue experiments to confirm specificity
Lessons from mammalian TMEM56 studies suggest that researchers should pay particular attention to:
Erythroid development and hematopoiesis phenotypes, given TMEM56's role in erythropoiesis
Haem metabolism, which may be disrupted by TMEM56 deficiency
Understanding the subcellular localization and trafficking of tmem56b requires specialized techniques:
Confocal microscopy:
Cell surface biotinylation:
Quantify surface expression using membrane-impermeable biotinylation reagents
Compare surface/total ratios under different experimental conditions
Fluorescence Recovery After Photobleaching (FRAP):
Assess protein mobility and membrane dynamics
Calculate diffusion coefficients to characterize membrane behavior
Super-resolution microscopy:
Employ STORM or PALM techniques for nanoscale resolution of protein clusters
Analyze co-localization with interacting partners at the nanoscale level
For co-localization studies, researchers can apply the methodology used for other transmembrane proteins:
Stain the plasma membrane with 0.5% (v/v) CellBrite Red solution containing DiD for 12 minutes at 37°C
Wash cells with PBS and fix with PFA
Counterstain nuclei with Hoechst-33342
Image using confocal microscopy with appropriate filters for each fluorophore
Studying tmem56b in zebrafish offers valuable insights into protein evolution across vertebrate species. The conservation and divergence of TMEM56 family members can reveal:
Functional domain conservation:
Identifying conserved regions suggests evolutionary pressure to maintain critical functions
Divergent regions may represent species-specific adaptations
Expression pattern evolution:
Comparing tissue-specific expression across species (zebrafish vs. mammals)
Relating expression differences to physiological adaptations
Interaction network evolution:
Examining how protein-protein interaction networks involving TMEM56 family members have evolved
Identifying conserved interaction partners that suggest core functional complexes
The findings from human TMEM56 studies showing its role in erythropoiesis and haem metabolism provide a foundation for comparative studies. Researchers can investigate whether zebrafish tmem56b serves similar functions or has evolved distinct roles in teleost physiology.
For comparing treatment effects:
For dose-response experiments:
Use non-linear regression to fit appropriate models (e.g., sigmoidal dose-response)
Report EC50/IC50 values with confidence intervals
For time-course experiments:
Apply repeated measures ANOVA or mixed-effects models
Consider autocorrelation structures when appropriate
Sample size considerations:
Conduct power analysis before experiments to determine appropriate sample sizes
Report effect sizes along with p-values to indicate biological significance
When analyzing factorial experiments involving tmem56b manipulations and additional factors, researchers should employ full factorial analysis to identify main effects and interactions . This approach is particularly valuable when studying how tmem56b function might be modulated by different conditions or genetic backgrounds.
The evolutionary conservation between zebrafish tmem56b and human TMEM56 suggests potential translational relevance:
Hematological disorders:
Drug discovery applications:
High-throughput screening in zebrafish tmem56b models
Identification of compounds that modulate tmem56b function or rescue deficiency phenotypes
Precision medicine approaches:
Understanding how genetic variants in TMEM56 contribute to disease phenotypes
Developing targeted therapies based on mechanistic insights
Recent studies showing that TMEM56 deficiency disrupts haem biosynthesis and impairs erythroid differentiation suggest its potential as a therapeutic target for erythropoietic disorders . Zebrafish models offer advantages for initial drug screening due to their:
Optical transparency during development
High fecundity and rapid development
Compatibility with high-throughput screening platforms